AIM ImmunoTech to Participate in the Virtual Investor Summer Spotlight Series
05 juil. 2023 08h35 HE
|
AIM ImmunoTech Inc.
OCALA, Fla., July 05, 2023 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), an immuno-pharma company focused on the research and development of therapeutics to...
Kinarus Therapeutics Shareholders Approve All Board Proposals at the 2023 Annual General Meeting
29 juin 2023 12h00 HE
|
Kinarus Therapeutic Holding AG
Basel, Switzerland, 29 June 2023. Kinarus Therapeutics Holding AG (SIX: KNRS) (“Kinarus” or the "Company"), a clinical-stage biopharmaceutical company developing novel therapeutics to treat viral,...
Kinarus Therapeutics signed subordinated bridge loans to ensure further liquidity
27 juin 2023 01h00 HE
|
Kinarus Therapeutic Holding AG
Basel, Switzerland, June 26, 2023 – Kinarus Therapeutics Holding AG (“Kinarus”) (SIX: KNRS), a clinical-stage biopharmaceutical company developing novel therapeutics to treat viral, respiratory and...
DriveThru Urgent Care launches game-changing approach to help patients get better faster
20 juin 2023 11h35 HE
|
Viral Solutions LLC
ATLANTA, June 20, 2023 (GLOBE NEWSWIRE) -- This summer, DriveThru Urgent Care — by Viral Solutions — will usher in a groundbreaking era of healthcare by treating patients with time-sensitive medical...
HLA Testing Market - 7.5% CAGR for Human Leukocyte Antigen Testing Market Size Worth $1.15 Billion, Globally, by 2028 – The Insight Partners
19 juin 2023 09h21 HE
|
The Insight Partners
Pune, India, June 19, 2023 (GLOBE NEWSWIRE) -- According to our latest study on "Human Leukocyte Antigen (HLA) Testing Market Size Report, Forecast to 2028 – COVID-19 Impact and Global Analysis – by...
Vielight Inc. Receives Health Canada Approval for Treatment of Covid-19 with Near Infrared Device Technology
14 juin 2023 16h13 HE
|
Vielight Inc.
Toronto, Canada, June 14, 2023 (GLOBE NEWSWIRE) -- Update to Release on Globe Newswire from May 25, 2023 13:30 ET Vielight announced on Thursday, May 25, 2023 that its Vielight RX Plus device -...
mRNA Vaccines and Therapeutics Market Size is projected to reach USD 58.92 billion by 2031, growing at a CAGR of 13.3%: Straits Research
08 juin 2023 11h00 HE
|
Straits Research
New York, United States, June 08, 2023 (GLOBE NEWSWIRE) -- mRNA-based therapeutics and vaccines permit the combination of desirable immunological properties. These are manufactured in the laboratory...
Kinarus Therapeutics Publishes Invitation to the 2023 Annual General Meeting
02 juin 2023 01h00 HE
|
Kinarus Therapeutic Holding AG
Basel, Switzerland, 2 June 2023. Kinarus Therapeutics Holding AG (SIX: KNRS) (“Kinarus” or the "Company"), a clinical-stage biopharmaceutical company developing novel therapeutics to treat viral,...
GeoVax Partners With ABL to Advance cGMP Production of Vaccine Candidates
31 mai 2023 09h00 HE
|
GeoVax, Inc.
ATLANTA, GA, May 31, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious...
Kinarus Therapeutics Group Reports 2022 Annual Results
31 mai 2023 01h00 HE
|
Kinarus Therapeutic Holding AG
Publishes Annual Report with Audited Consolidated Financial Results for Year Ended 31 December 2022Clinical efforts re-focused on developing KIN001 for original indications IPF and wet AMDCDIM CHF1.5...